Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$24.65 - $29.0 $218,842 - $257,462
-8,878 Closed
0 $0
Q4 2021

Jun 21, 2023

BUY
$27.74 - $34.09 $246,275 - $302,651
8,878 New
8,878 $251,000
Q4 2021

Mar 30, 2023

SELL
$27.74 - $34.09 $9,154 - $11,249
-330 Reduced 3.58%
8,878 $251,000
Q4 2021

Feb 15, 2022

BUY
$27.74 - $34.09 $246,275 - $302,651
8,878 New
8,878 $252,000
Q3 2021

Jun 21, 2023

BUY
$29.2 - $36.72 $258,536 - $325,118
8,854 New
8,854 $282 Million
Q3 2021

Nov 15, 2021

SELL
$29.2 - $36.72 $268,873 - $338,117
-9,208 Closed
0 $0
Q2 2021

Jun 21, 2023

BUY
$28.76 - $35.98 $264,822 - $331,303
9,208 New
9,208 $319,000
Q2 2021

Mar 30, 2023

BUY
$28.76 - $35.98 $10,324 - $12,916
359 Added 4.06%
9,208 $319,000
Q2 2021

Aug 16, 2021

BUY
$28.76 - $35.98 $264,822 - $331,303
9,208 New
9,208 $319,000
Q1 2021

Jun 26, 2023

BUY
$27.85 - $34.49 $256,359 - $317,480
9,205 New
9,205 $271 Million
Q1 2021

May 14, 2021

SELL
$27.85 - $34.49 $246,444 - $305,202
-8,849 Closed
0 $0
Q4 2020

Jun 22, 2023

BUY
$27.53 - $33.79 $243,612 - $299,007
8,849 New
8,849 $271,000
Q4 2020

Mar 30, 2023

BUY
$27.53 - $33.79 $22,629 - $27,775
822 Added 10.24%
8,849 $271,000
Q4 2020

Feb 16, 2021

BUY
$27.53 - $33.79 $22,629 - $27,775
822 Added 10.24%
8,849 $271,000
Q3 2020

Jun 26, 2023

BUY
$21.1 - $29.13 $169,369 - $233,826
8,027 New
8,027 $224,000
Q3 2020

Mar 30, 2023

SELL
$21.1 - $29.13 $2,426 - $3,349
-115 Reduced 1.41%
8,027 $224,000
Q3 2020

Nov 13, 2020

SELL
$21.1 - $29.13 $2,426 - $3,349
-115 Reduced 1.41%
8,027 $224,000
Q2 2020

Jun 26, 2023

BUY
$18.94 - $24.93 $154,209 - $202,980
8,142 New
8,142 $174,000
Q2 2020

Mar 30, 2023

SELL
$18.94 - $24.93 $27,955 - $36,796
-1,476 Reduced 15.35%
8,142 $174,000
Q2 2020

Aug 14, 2020

SELL
$18.94 - $24.93 $27,955 - $36,796
-1,476 Reduced 15.35%
8,142 $175,000
Q1 2020

Jul 12, 2023

BUY
$16.68 - $32.25 $160,428 - $310,180
9,618 New
9,618 $215,000
Q1 2020

Mar 30, 2023

BUY
$16.68 - $32.25 $9,207 - $17,802
552 Added 6.09%
9,618 $215,000
Q1 2020

May 15, 2020

BUY
$16.68 - $32.25 $9,207 - $17,802
552 Added 6.09%
9,618 $215,000
Q4 2019

Jul 12, 2023

BUY
$25.29 - $29.45 $229,279 - $266,993
9,066 New
9,066 $266,000
Q4 2019

Mar 30, 2023

BUY
$25.29 - $29.45 $758 - $883
30 Added 0.33%
9,066 $266,000
Q4 2019

Feb 14, 2020

BUY
$25.29 - $29.45 $758 - $883
30 Added 0.33%
9,066 $267,000
Q3 2019

Jul 12, 2023

BUY
$25.62 - $34.96 $231,502 - $315,898
9,036 New
9,036 $240,000
Q3 2019

Mar 30, 2023

SELL
$25.62 - $34.96 $173,063 - $236,154
-6,755 Reduced 42.78%
9,036 $240,000
Q3 2019

Nov 14, 2019

SELL
$25.62 - $34.96 $173,063 - $236,154
-6,755 Reduced 42.78%
9,036 $240,000
Q2 2019

Jul 12, 2023

BUY
$31.11 - $34.79 $491,258 - $549,368
15,791 New
15,791 $533,000
Q2 2019

Mar 30, 2023

SELL
$31.11 - $34.79 $8,275 - $9,254
-266 Reduced 1.66%
15,791 $533,000
Q2 2019

Aug 14, 2019

SELL
$31.11 - $34.79 $8,275 - $9,254
-266 Reduced 1.66%
15,791 $534,000
Q1 2019

Jul 13, 2023

BUY
$29.0 - $32.83 $465,653 - $527,151
16,057 New
16,057 $514,000
Q1 2019

Mar 30, 2023

BUY
$29.0 - $32.83 $465,653 - $527,151
16,057 New
16,057 $514,000
Q1 2019

May 16, 2019

BUY
$29.0 - $32.83 $317,144 - $359,028
10,936 Added 213.55%
16,057 $514,000
Q1 2019

May 15, 2019

BUY
$29.0 - $32.83 $45,182 - $51,149
1,558 Added 43.73%
5,121 $135,000
Q4 2018

Jul 13, 2023

BUY
$29.63 - $34.5 $105,571 - $122,923
3,563 New
3,563 $112,000
Q4 2018

Feb 14, 2019

BUY
$29.63 - $34.5 $105,571 - $122,923
3,563 New
3,563 $112,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.